BamSEC and AlphaSense Join Forces
Learn More

Outlook Therapeutics Inc. – Transcripts

NASDAQ: OTLK    
Share price (9/21/26): $0.69    
Market cap (9/21/26): $167 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2026
Earnings Revised 08/14/26 Outlook Therapeutics, Inc., Q3 2026 Earnings Call, Aug 14, 2026 08/14/26
CY 2025
Other Revised 08/28/25 Outlook Therapeutics, Inc. - Special Call 08/28/25
Other Revised 06/25/25 Outlook Therapeutics, Inc. - Special Call 06/25/25
Other Revised 02/04/25 Outlook Therapeutics, Inc. - Special Call 02/03/25
CY 2024
Earnings Revised 08/14/24 Outlook Therapeutics, Inc., Q3 2024 Earnings Call, Aug 14, 2024 08/14/24
Earnings Revised 05/16/24 Outlook Therapeutics, Inc., Q2 2024 Earnings Call, May 16, 2024 05/16/24
CY 2023
Other Revised 08/30/23 Outlook Therapeutics, Inc. - Special Call 08/30/23
CY 2022
Other Revised 05/11/22 Outlook Therapeutics, Inc. - Special Call 05/11/22
CY 2021
Other Revised 08/03/21 Outlook Therapeutics, Inc. - Special Call 08/03/21
Other Revised 05/20/21 Outlook Therapeutics, Inc. - Special Call 05/20/21
CY 2020
Other Revised 10/29/20 Outlook Therapeutics, Inc. Presents at Virtual Investor KOL Roundtable, Oct-29-2020 10:00 AM 10/29/20